Licensing

New Drug Candidates

Unibest partners with numerous biotech and pharmaceutical firms around the world, facilitating the successful in-licensing and out-licensing of intellectual property (IP) at every stage of new drug development and commercialization. Our core mission is to connect global pharmaceutical resources, helping to create a healthier future for all.

View all pipelines

Core Business

Our five-step framework for successful global licensing partnerships.

Regulatory and Compliance Support

Unibest provides tailored consulting and compliance advice for navigating international drug regulations. We facilitate communication with local authorities to accelerate approvals and market entry.

Project Screening and Evaluation

Regulatory requirements vary by country. Unibest uses its self-developed "Digital Intelligence Platform" to offer tailored consulting that helps companies navigate overseas registration, compliance, and achieve faster market entry.

Partner Selection and Matching

Unibest connects with qualified local partners and aligns on strategy and commercial goals early, maximizing the likelihood of successful collaboration through industry networks and targeted outreach.

Transaction Negotiation and Signing

Unibest negotiates cooperation terms, financial arrangements, and responsibilities, and drafts or reviews legal documents to ensure both parties' rights, obligations, and compliance are fully protected.

Post-collaboration Supports

After the licensing agreement, Unibest provides ongoing project management, clinical trial updates, and marketing support, as well as coordination and negotiation assistance if disputes arise during the partnership.

How can we help you?

Receive insights into the latest events and regulatory updates

Sent directly to your email

Get industry insights and Unibest news here